<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-27</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-27</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>89</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ä¸€é¡¹ç ”ç©¶æ­ç¤ºäº†CD8 Tç»†èƒåœ¨éè£‚è§£æ€§ç—…æ¯’ç–«è‹—è¯±å¯¼çš„æŒä¹…æ€§å…ç–«ä¸­å‘æŒ¥çš„å…³é”®ä½œç”¨ï¼Œé€šè¿‡è§¦å‘Iå‹å¹²æ‰°ç´ å®ç°ã€‚ç»†èŒCARD-NLRå…ç–«ç³»ç»Ÿåœ¨æ§åˆ¶åŸºå› è½¬ç§»å› å­é‡Šæ”¾æ–¹é¢å±•ç°äº†æ–°æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- <strong>è‚¿ç˜¤å…ç–«ä¸æ²»ç–—</strong>ï¼šæ¢è®¨IL-4åœ¨è‚¿ç˜¤å…ç–«ä¸­çš„è¡¨è§‚é—ä¼ è°ƒæ§ï¼Œä»¥åŠDAB2IPã€LncRNA SLC16A1-AS1ã€SF3B1-K700Eç­‰åœ¨è‚¿ç˜¤å‘ç”Ÿå‘å±•ä¸­çš„ä½œç”¨ï¼Œå¹¶ç ”ç©¶ ferroptosis è¯±å¯¼å¯¹ç™Œç—‡å…ç–«æ²»ç–—çš„å¢å¼ºæ•ˆåº”ã€‚<br />
- <strong>å…ç–«ç»†èƒåŠŸèƒ½ä¸è°ƒæ§</strong>ï¼šèšç„¦CD8 Tç»†èƒã€ILC3sã€CD4 Tç»†èƒç­‰åœ¨è‚¿ç˜¤æŠ‘åˆ¶ã€è‚ é“å±éšœä¿æŠ¤ã€ç»„ç»‡é©»ç•™å…ç–«ç½‘ç»œä¸­çš„ä½œç”¨ã€‚<br />
- <strong>æ„ŸæŸ“ä¸ç–«è‹—ç ”ç©¶</strong>ï¼šé˜æ˜ç—…æ¯’ç–«è‹—è½½ä½“è¯±å¯¼Tç»†èƒå…ç–«çš„æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç»“åˆå•ç»†èƒè½¬å½•ç»„å­¦ï¼ˆscRNA-Seqï¼‰ä¸å…¨åŸºå› ç»„æµ‹åºæŠ€æœ¯ï¼ˆCUT&amp;Tag, ChIP-Seq, Tn-Seqï¼‰æ·±å…¥è§£æå…ç–«é€šè·¯å’ŒåŸºå› è°ƒæ§ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡å‘ç°å¸¦çŠ¶ç–±ç–¹ç–«è‹—å¯èƒ½å»¶ç¼“ç”Ÿç‰©è¡°è€å¹¶é™ä½ç‚ç—‡ï¼›ç ”ç©¶æ­ç¤ºå¾®å¡‘æ–™åœ¨90%å‰åˆ—è…ºç™Œè‚¿ç˜¤ä¸­æ™®éå­˜åœ¨ï¼Œä¸”å«é‡è¿œé«˜äºå¥åº·ç»„ç»‡ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢å¸¦çŠ¶ç–±ç–¹ç–«è‹—å¯¹è€å¹´äººç”Ÿç‰©è¡°è€åŠç‚ç—‡æ°´å¹³çš„å½±å“ã€‚<br />
- é‰´å®šä¸è¡°è€ç›¸å…³çš„çº¿ç²’ä½“ç¯çŠ¶RNAï¼ˆcircRNAï¼‰åŠå…¶åœ¨ç»†èƒè¡°è€å’Œçº¿ç²’ä½“ä»£è°¢ä¸­çš„ä½œç”¨ã€‚<br />
- æ£€æµ‹å‰åˆ—è…ºç™Œè‚¿ç˜¤ç»„ç»‡ä¸­çš„å¾®å¡‘æ–™æ±¡æŸ“åŠå…¶æ½œåœ¨å…³è”ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åˆ©ç”¨RNAæµ‹åºï¼ˆRNA-Seqï¼‰æŠ€æœ¯é‰´å®šä¸è¡°è€ç›¸å…³çš„çº¿ç²’ä½“circRNAã€‚<br />
- å¼€å‘ç”¨æˆ·å‹å¥½çš„ERSAtoolï¼Œç®€åŒ–RNAæµ‹åºæ•°æ®åˆ†ææµç¨‹ï¼Œä¾¿äºæ•™å­¦åº”ç”¨ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (85æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE315254 Smyd5 ä»‹å¯¼ IL-4 è¡¨è§‚é—ä¼ æ§åˆ¶å·¨å™¬ç»†èƒæŠ—åŸå‘ˆé€’ï¼Œä»è€Œé©±åŠ¨ååŒ T ç»†èƒä»‹å¯¼çš„è‚¿ç˜¤æŠ‘åˆ¶ [CUT&amp;Tag]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€T cellã€macrophageã€antigenã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Buyun Dang ; Yuling Hong ; Qingxiang Gao ; Shih-Chin ChengSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusIL-4 is classically associated with â€œM2â€ macrophages considered tumor-immunosuppressive, yet marker-based labels poorly reflect macrophage function in tumors. Reports of a non-canonical, IL-4â€“imprinted macrophage state (M2inf) with trained-immunity features prompted us to test whether such imprinting contributes to antitumor immunity in vivo. Here we show that, in B16F10 melanoma, IL-4 programs macrophages through the lysine methyltransferase Smyd5 to deposit promoter-proximal H3K36me3, increase MHC class II, and potentiate T cell activation. Myeloid Il4ra deletion increased tumor burden and reduced MHC class II and intratumoral T cell activation, whereas co-transfer of IL-4â€“primed macrophages suppressed tumors and expanded activated CD4 and CD8 T cells. Antitumor benefit required adaptive lymphocytes and macrophage-intrinsic MHC class II, as Rag1 deficiency or macrophage Rfx5 deletion abrogated tumor suppression. These findings identify a non-canonical, IL-4â€“imprinted macrophage program that enables antigen presentation and cooperative T cell immunity in this tumor context.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315254" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE317029 éç»†èƒæº¶è§£æ€§ç—…æ¯’ç–«è‹—è½½ä½“é€šè¿‡è§¦å‘ I å‹å¹²æ‰°ç´ è¯±å¯¼æŒä¹…çš„æ•ˆåº”è®°å¿† CD8 T ç»†èƒå…ç–« [scRNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€vaccineã€T cellã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Matias Ciancaglini ; Robin Avanthay ; Anna-Friederike Marx ; Tiago Abreu-Mota ; Davide Finozzi ; Jonas Fixemer ; Florian Geier ; Dominik Burri ; Ingrid Wagner ; Ilena Vincenti ; Mario Kreuzfeld ; Doron Merkler ; Gert Zimmer ; Daniel D PinschewerSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusReplication-deficient viral vector systems hold promise for CD8 T cell-based vaccination, but the molecular mechanisms accounting for platform-specific differences in immunogenicity remain ill-defined. Here we compared lymphocytic choriomeningitis virus- (rLCMV) and vesicular stomatitis virus-based (rVSV) single-cycle vectors to explore vector-specific features determining long-lived effector-memory CD8 T cell induction. rLCMV, a non-cytolytic vector, elicited more durable CD8 T cell responses and a higher proportion of effector-memory CD8 T cells than cytolytic rVSV. When rVSV was re-engineered to be non-cytolytic (rVSVMq), also this vector induced durable and effector-differentiated CD8 T cell memory, reminiscent of rLCMV-induced responses, and it afforded superior protection against Listeria challenge than rVSV. Improved CD8 T cell responses of non-cytolytic rVSVMq depended on an elevated type I interferon (IFN-I) response and its direct sensing by vaccination-induced CD8 T cells. Many rVSVMq-infected cells in the splenic marginal zone that were in contact with antigen-specific CD8 T cells expressed not only vectorized antigen but also IFN-I, suggesting that non-cytolytic viral vectors promote the integration of peptide-MHC and IFN-I signals during T cell activation. These mechanistic insights should help to refine vaccines aimed at eliciting durable and protective effector-memory CD8 T cell immunity.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317029" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE310552 DAB2IP é€šè¿‡å¢å¼ºè‚ é“ ILC3 åŠŸèƒ½æ¥è°ƒèŠ‚è‚ é“ç‚ç—‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Liang Liu ; Zhiheng HeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGroup 3 innate lymphoid cells (ILC3s) protect the intestinal barrier by producing IL-22 and IL-17A, yet the molecular mechanisms that sustain their cytokine output during inflammation remain poorly defined. Here, we identify the cytosolic scaffold DAB2IP as a critical ILC3-intrinsic regulator of effector function. In human IBD, DAB2IP expression is reduced in inflamed tissues, correlating with impaired epithelial repair and decreased IL-22. In mice, DAB2IP expression in ILC3s declines during intestinal inflammation, and silencing DAB2IP markedly diminishes IL-22 and IL-17A production. Adoptive transfer of Dap2ip-deficient ILC3s exacerbates DSS-induced colitis and increases susceptibility to Citrobacter rodentium. Mechanistically, DAB2IP promotes NF-ÎºB activation, sustaining transcription of Il22 and Il17a. These results reveal a context-dependent role for DAB2IP as a positive regulator of NF-ÎºB in ILC3s, highlighting its previously unknown function in mucosal immunity and epithelial repair, and suggesting that restoring DAB2IP signaling could enhance barrier protection during intestinal inflammation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310552" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE311208 å•ç»†èƒå’Œæ‰¹é‡ RNA æµ‹åºç›¸ç»“åˆæ­ç¤ºéª¨é«“ç‚ä¸­å…ç–«å¾®ç¯å¢ƒçš„å˜åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€RNA-seqã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhenhua Zhu ; Xiaopeng Jing ; Jun Chen ; Jie Tan ; Ji Zeng ; Zheng JinSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusObjective: This study profiled the osteomyelitis immune micro-environment in depth, pinpointed driver genes and cell populations that fuel disease progression, and mined the data for actionable drug targets. Methods: We analyzed time-series transcriptomic sequencing data from mouse tibial osteomyelitis samples in dataset GSE168896. Fuzzy c-means clustering was applied to reveal gene sets linked to disease progression. Immune cell infiltration analysis was conducted through online tool ImmuCellAI-mouse. Furthermore, by leveraging single-cell sequencing data, we characterized immune cell subpopulations and pinpointed the key cell subtypes that exhibited in osteomyelitis mouse. Results: We identified six gene clusters exhibiting distinct temporal expression patterns and functional roles in osteomyelitis processes, such as leukocyte and lymphocyte activation, ossification. Single-cell sequencing analysis further revealed 7 distinct cellular subpopulations. Among these, M2-like macrophages demonstrated a significant increase following osteomyelitis. Arg+Sdc4+ Mac and Cxcl1+Ccl4+ Mac were new subpopulations of macrophages that emerged after osteomyelitis, the infiltration of Mif+Cd63+ Mac significantly increased. Besides, Cxcl2-Cxcr2 ligand-receptors contributed mostly in immune cells.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311208" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE295580 ç»†èŒ CARD-NLR å…ç–«ç³»ç»Ÿæ§åˆ¶åŸºå› è½¬ç§»å› å­çš„é‡Šæ”¾ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€regex:bacter(ia|ial|ium)ã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Emma Banks ; Tung LeSeries Type : Expression profiling by high throughput sequencingOrganism : Caulobacter vibrioidesBacteria have evolved a wide array of immune systems to detect and defend against external threats including mobile genetic elements (MGEs) such as bacteriophages, plasmids, and transposons. MGEs are often selfish, exploiting their bacterial hosts to propagate, however they can also provide adaptive advantages through horizontal gene transfer. Gene transfer agents (GTAs), which are non-infectious domesticated prophages, represent a unique class of beneficial MGEs that facilitate bacterial gene transfer. Despite their domestication, GTAs retain phage-like features, including the requirement for host cell lysis to release particles, that may inadvertently trigger host immunity. How GTAs might avoid, subvert, or possibly adopt host immune systems to complete their life stages is poorly understood. Here, we identify a tripartite system, LypABC, that is essential for GTA-mediated cell lysis in Caulobacter crescentus. LypABC resembles caspase recruitment domain-nucleotide-binding leucine-rich repeat (CARD-NLR) anti-phage defence systems that mediate abortive infection wherein infected cells die to prevent phage proliferation, thereby protecting the overall bacterial population. LypABC-deficient cells produce host DNA-packed GTA particles and eventually die but cannot lyse to release GTA particles. Moreover, overproduction of LypABC is highly toxic to both GTA-producing and non-producing cells, highlighting the need for strict regulation. We find that such regulation is achieved transcriptionally by a repressor, CdxB, which binds the promoters of lypABC and of essential GTA activator genes, thus coupling GTA activation and host cell lysis. While traditionally considered antagonistic towards MGEs, our findings here suggest that immunity components are versatile and can be adapted to support MGEs.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295580" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE295577 ç»†èŒ CARD-NLR å…ç–«ç³»ç»Ÿæ§åˆ¶åŸºå› è½¬ç§»å‰‚çš„é‡Šæ”¾ [ChIP-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€regex:bacter(ia|ial|ium)ã€ChIP-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Emma Banks ; Tung LeSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Caulobacter vibrioidesBacteria have evolved a wide array of immune systems to detect and defend against external threats including mobile genetic elements (MGEs) such as bacteriophages, plasmids, and transposons. MGEs are often selfish, exploiting their bacterial hosts to propagate, however they can also provide adaptive advantages through horizontal gene transfer. Gene transfer agents (GTAs), which are non-infectious domesticated prophages, represent a unique class of beneficial MGEs that facilitate bacterial gene transfer. Despite their domestication, GTAs retain phage-like features, including the requirement for host cell lysis to release particles, that may inadvertently trigger host immunity. How GTAs might avoid, subvert, or possibly adopt host immune systems to complete their life stages is poorly understood. Here, we identify a tripartite system, LypABC, that is essential for GTA-mediated cell lysis in Caulobacter crescentus. LypABC resembles caspase recruitment domain-nucleotide-binding leucine-rich repeat (CARD-NLR) anti-phage defence systems that mediate abortive infection wherein infected cells die to prevent phage proliferation, thereby protecting the overall bacterial population. LypABC-deficient cells produce host DNA-packed GTA particles and eventually die but cannot lyse to release GTA particles. Moreover, overproduction of LypABC is highly toxic to both GTA-producing and non-producing cells, highlighting the need for strict regulation. We find that such regulation is achieved transcriptionally by a repressor, CdxB, which binds the promoters of lypABC and of essential GTA activator genes, thus coupling GTA activation and host cell lysis. While traditionally considered antagonistic towards MGEs, our findings here suggest that immunity components are versatile and can be adapted to support MGEs.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295577" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE317032 éç»†èƒæº¶è§£æ€§ç—…æ¯’ç–«è‹—è½½ä½“é€šè¿‡è§¦å‘ I å‹å¹²æ‰°ç´ è¯±å¯¼æŒä¹…çš„æ•ˆåº”è®°å¿† CD8 T ç»†èƒå…ç–«</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€vaccineã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317032" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE317031 éç»†èƒæº¶è§£æ€§ç—…æ¯’ç–«è‹—è½½ä½“é€šè¿‡è§¦å‘ I å‹å¹²æ‰°ç´ è¯±å¯¼æŒä¹…çš„æ•ˆåº”è®°å¿† CD8 T ç»†èƒå…ç–« [TCR-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€vaccineã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Matias Ciancaglini ; Robin Avanthay ; Anna-Friederike Marx ; Tiago Abreu-Mota ; Davide Finozzi ; Jonas Fixemer ; Florian Geier ; Dominik Burri ; Ingrid Wagner ; Ilena Vincenti ; Mario Kreuzfeld ; Doron Merkler ; Gert Zimmer ; Daniel D PinschewerSeries Type : OtherOrganism : Mus musculusReplication-deficient viral vector systems hold promise for CD8 T cell-based vaccination, but the molecular mechanisms accounting for platform-specific differences in immunogenicity remain ill-defined. Here we compared lymphocytic choriomeningitis virus- (rLCMV) and vesicular stomatitis virus-based (rVSV) single-cycle vectors to explore vector-specific features determining long-lived effector-memory CD8 T cell induction. rLCMV, a non-cytolytic vector, elicited more durable CD8 T cell responses and a higher proportion of effector-memory CD8 T cells than cytolytic rVSV. When rVSV was re-engineered to be non-cytolytic (rVSVMq), also this vector induced durable and effector-differentiated CD8 T cell memory, reminiscent of rLCMV-induced responses, and it afforded superior protection against Listeria challenge than rVSV. Improved CD8 T cell responses of non-cytolytic rVSVMq depended on an elevated type I interferon (IFN-I) response and its direct sensing by vaccination-induced CD8 T cells. Many rVSVMq-infected cells in the splenic marginal zone that were in contact with antigen-specific CD8 T cells expressed not only vectorized antigen but also IFN-I, suggesting that non-cytolytic viral vectors promote the integration of peptide-MHC and IFN-I signals during T cell activation. These mechanistic insights should help to refine vaccines aimed at eliciting durable and protective effector-memory CD8 T cell immunity.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317031" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE306901 äº¬éƒ½é€æ˜ç»†èƒç™Œé˜Ÿåˆ—çš„ RNA-seqã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensFresh frozen tumor tissues from 38 cases diagnosed as clear cell carcinoma (CCC) were submitted to total RNA-sequencing.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306901" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE300837 PM2.5æš´éœ²çš„é—ä¼ æ˜“æ„Ÿæ€§é©±åŠ¨å„¿ç«¥å“®å–˜çš„è½¬å½•ååº”ï¼šæ¥è‡ªå•ç»†èƒè½¬å½•ç»„å­¦çš„å¯ç¤º</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jelte Kelchtermans ; Huiqi Qu ; Cuiping Hou ; Frank Mentch ; Sharon A McGrath-Morrow ; Hakon HakonarsonSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensBackground. Exposure to fine particulate matter (PM2.5) increases asthma severity and reduces glucocorticoid responsiveness in children, yet the molecular mechanisms underlying PM2.5 sensitivity remain unclear. We previously identified a PM2.5-sensitive asthma phenotype and developed a PM2.5 sensitivity polygenic risk score (sPRS) correlated with asthma exacerbations and lung function decline. This study expands on these results using genetic mapping and single-cell transcriptomics to elucidate the biological pathways mediating PM2.5 sensitivity and generate hypotheses regarding potential therapeutic targets. Research Question. We aimed to determine whether genetic variants associated with PM2.5 sensitivity converge on specific pathways or transcriptional regulators and assess their role in glucocorticoid responsiveness. Methods. We mapped sPRS variants to genes using regulatory annotation tools and performed pathway enrichment analysis. Single-cell RNA sequencing (scRNA-seq) was conducted on peripheral blood mononuclear cells (PBMCs) from patients stratified by sPRS and matched by PM2.5 exposure to identify transcriptional perturbations in response to PM2.5 exposure. In silico analyses predicted regulatory networks and small molecules that could modulate these pathways. Results. sPRS-associated genes were enriched for SMAD2/3 and MAPK signaling, implicating TGF-Î²1 as a key mediator of PM2.5 sensitivity. scRNA-seq revealed immune cell-specific transcriptional changes linked to inflammation. Notably, HDM2 inhibition downregulated the PM2.5-sensitive transcriptomic signature, suggesting a role in restoring glucocorticoid responsiveness. Interpretation. Our findings suggest a TGF-Î²1â€“HDM2â€“p53 axis may contribute to PM2.5-induced glucocorticoid resistance and identify HDM2 as a potential therapeutic target for future investigation in PM2.5-sensitive children with asthma.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300837" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 75 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>å¸¦çŠ¶ç–±ç–¹ç–«è‹—å¯èƒ½å»¶ç¼“ç”Ÿç‰©è¡°è€å¹¶å‡è½»ç‚ç—‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼švaccineã€agingã€inflammation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA shingles shot might do more than prevent a painful rash â€” it could actually help slow down the aging process. In a large national study of more than 3,800 Americans age 70 and older, those who received the shingles vaccine showed slower biological aging compared to those who didnâ€™t. Researchers found lower levels of chronic inflammation and slower changes in gene activity linked to aging, suggesting the vaccine may calm the bodyâ€™s â€œinflammagingâ€ â€” the low-grade inflammation tied to heart disease, frailty, and cognitive decline.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260225081153.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>RNAæµ‹åºé‰´å®šå‡ºä¸è¡°è€ç›¸å…³çš„çº¿ç²’ä½“ç¯çŠ¶RNA</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šUsing RNA sequencing of human PBMCs, researchers identify aging-associated mitochondrial circular RNAs and link circMT-RNR2 and GRSF1 to mitochondrial metabolism and cellular senescence...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rna-seq-identifies-aging-associated-mitochondrial-circular-rnas/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ä¸€æ¬¾ç”¨æˆ·å‹å¥½çš„å·¥å…·å°†RNAæµ‹åºåˆ†æå¼•å…¥è¯¾å ‚ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šERSAtool simplifies RNA sequencing analysis through an interactive R Shiny interface, guiding users from normalization to differential expression and functional analysis without requiring advanced coding skills...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/a-user-friendly-tool-brings-rna-sequencing-analysis-to-the-classroom/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>ç ”ç©¶æ˜¾ç¤ºï¼Œ90%çš„å‰åˆ—è…ºç™Œè‚¿ç˜¤ä¸­éƒ½å‘ç°äº†å¾®å¡‘æ–™ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue. Scientists say this is the first Western study to directly measure plastic particles in prostate tumors. More research is needed, but the findings suggest microplastic exposure could play a role in cancer development.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260225001250.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>16</td>
</tr>
<tr>
<td>cancer</td>
<td>12</td>
</tr>
<tr>
<td>immune</td>
<td>11</td>
</tr>
<tr>
<td>single-cell</td>
<td>6</td>
</tr>
<tr>
<td>T cell</td>
<td>6</td>
</tr>
<tr>
<td>sequencing</td>
<td>5</td>
</tr>
<tr>
<td>aging</td>
<td>5</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>5</td>
</tr>
<tr>
<td>inflammation</td>
<td>5</td>
</tr>
<tr>
<td>immunity</td>
<td>5</td>
</tr>
<tr>
<td>genome</td>
<td>5</td>
</tr>
<tr>
<td>carcinoma</td>
<td>4</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>4</td>
</tr>
<tr>
<td>histone</td>
<td>4</td>
</tr>
<tr>
<td>vaccine</td>
<td>4</td>
</tr>
<tr>
<td>tumor</td>
<td>4</td>
</tr>
<tr>
<td>scRNA</td>
<td>3</td>
</tr>
<tr>
<td>regex:bacter(ia</td>
<td>ial</td>
</tr>
<tr>
<td>regex:onco(logy</td>
<td>logist</td>
</tr>
<tr>
<td>pathway</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (75æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295581" target="_blank" rel="noopener noreferrer">GSE295581 ç»†èŒ CARD-NLR å…ç–«ç³»ç»Ÿæ§åˆ¶åŸºå› è½¬ç§»å› å­çš„é‡Šæ”¾ [Tn-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292453" target="_blank" rel="noopener noreferrer">GSE292453 éª¨å…³èŠ‚ç‚å¤šéƒ¨ä½ç»†èƒç–—æ³•çš„å•ç»†èƒè½¬å½•ç»„å­¦ï¼šç»„ç»‡ç‰¹å¼‚æ€§ç‰¹å¾å’Œæ²»ç–—ç›¸å…³æ€§ [å®Œæ•´è¯•éªŒ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280004" target="_blank" rel="noopener noreferrer">GSE280004 å•ç»†èƒè½¬å½•ç»„å­¦æ­ç¤ºAgdb-åœ°ä¸­æµ·è´«è¡€ä¸­å¼‚è´¨ç»†èƒÎ³-ç è›‹ç™½åŸºå› è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269083" target="_blank" rel="noopener noreferrer">GSE269083 æ•²ä½ PRCC-TFE3 èåˆåŸºå› å TFE3 é‡æ’è‚¾ç»†èƒç™Œ UOK120 ç»†èƒç³»çš„åŸºå› å·®å¼‚è¡¨è¾¾åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244979" target="_blank" rel="noopener noreferrer">GSE244979 ä¿å®ˆçš„è½¬å½•ååº”å¯¹é€†å¢ƒç›¸å…³ç‚ç—‡æœ‰å½±å“ï¼Œä¿ƒè¿›æ¢…å°¼åŸƒç—…è¿›å±• [RNA-Seq 2]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244978" target="_blank" rel="noopener noreferrer">GSE244978 ä¿å®ˆçš„è½¬å½•ååº”å¯¹é€†å¢ƒç›¸å…³ç‚ç—‡æœ‰å½±å“ï¼Œä¿ƒè¿›æ¢…å°¼åŸƒç—…è¿›å±• [RNA-Seq 1]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311114" target="_blank" rel="noopener noreferrer">GSE311114 è‡´ç™Œé•¿é“¾éç¼–ç RNA SLC16A1-AS1 ä¸ NSUN2 ååŒä½œç”¨ï¼Œé€šè¿‡ m5C ä¿®é¥°ç¨³å®šèƒƒç™Œä¸­çš„ GRP78 mRNA [AGS]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310529" target="_blank" rel="noopener noreferrer">GSE310529 è‡´ç™Œé•¿é“¾éç¼–ç RNA SLC16A1-AS1ä¸NSUN2ååŒä½œç”¨ï¼Œé€šè¿‡m5Cä¿®é¥°ç¨³å®šèƒƒç™Œä¸­çš„GRP78 mRNA</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310035" target="_blank" rel="noopener noreferrer">GSE310035 SF3B1-K700E é©±åŠ¨ç™Œç—‡ç»†èƒå‘¨æœŸæ£€æŸ¥ç‚¹åŸºå› çš„è‡´ç™Œæ€§é€‰æ‹©æ€§å‰ªæ¥</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304332" target="_blank" rel="noopener noreferrer">GSE304332 å•ç»†èƒ RNA æµ‹åºæ­ç¤ºä¸è‡ªèº«å…ç–«æ€§ç¥ç»ç‚ç—‡ç›¸å…³çš„å—œä¸­æ€§ç²’ç»†èƒç°‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302064" target="_blank" rel="noopener noreferrer">GSE302064 è½¬å½•ç»„åˆ†æ RAD52 æ•²é™¤å¯¹ BRCA2 ç¼ºé™·å‹ã€å¥¥æ‹‰å¸•å°¼è€è¯å°é¼ åµå·¢ç™Œç»†èƒ (ID8-OR) ä¸­å¥¥æ‹‰å¸•å°¼ååº”çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291400" target="_blank" rel="noopener noreferrer">GSE291400 HIF-1Î±+ CD4 T ç»†èƒåè°ƒè‚ºç»„ç»‡é©»ç•™å…ç–«ç»†èƒç½‘ç»œ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318000" target="_blank" rel="noopener noreferrer">GSE318000 Lnc-GATS-3:3/MCM7 é€šè¿‡è°ƒæ§ CDK/Rb/E2F ä¿¡å·é€šè·¯ä¿ƒè¿›å®«é¢ˆé³çŠ¶ç»†èƒç™Œç»†èƒçš„å¢æ®–å’Œä¾µè¢­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314706" target="_blank" rel="noopener noreferrer">GSE314706 å¯¹é…å¯¹çš„é¼»è…”åˆ·å–ç‰©å’Œç»„ç»‡æ ·æœ¬è¿›è¡Œå•ç»†èƒåˆ†æï¼Œæ­ç¤ºäº†ä¸åŒçš„ç»†èƒå›¾è°±å’Œå…ç–«è¡¨å‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292109" target="_blank" rel="noopener noreferrer">GSE292109 DGAT1æŠ‘åˆ¶è¯±å¯¼é“æ­»äº¡å¢å¼ºç™Œç—‡å…ç–«ç–—æ³•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320473" target="_blank" rel="noopener noreferrer">GSE320473 å·¨å™¬ç»†èƒé€šè¿‡Tcf4-Col3è½´æ§åˆ¶èƒ¶åŸè›‹ç™½æ‹“æ‰‘ç»“æ„ï¼Œä»è€Œé™åˆ¶è‚¿ç˜¤å…ç–«æµ¸æ¶¦3</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320163" target="_blank" rel="noopener noreferrer">GSE320163 åŸºå› ç»„ç¼–è¾‘ä¸­æœ€å¤§é™åº¦å‡å°‘å¤§èŒƒå›´æŸ“è‰²è´¨æ‰°åŠ¨å¯ä¿æŒå¹²ç»†èƒç‰¹æ€§ [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320162" target="_blank" rel="noopener noreferrer">GSE320162 åŸºå› ç»„ç¼–è¾‘ä¸­æœ€å¤§é™åº¦å‡å°‘å¤§èŒƒå›´æŸ“è‰²è´¨æ‰°åŠ¨å¯ä¿æŒå¹²ç»†èƒç‰¹æ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320161" target="_blank" rel="noopener noreferrer">GSE320161 åŸºå› ç»„ç¼–è¾‘ä¸­æœ€å¤§é™åº¦å‡å°‘è¿œè·ç¦»æŸ“è‰²è´¨æ‰°åŠ¨å¯ä¿æŒå¹²ç»†èƒç‰¹æ€§ [é•¿è¯»æ‰©å¢å­æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313953" target="_blank" rel="noopener noreferrer">GSE313953 ç ”ç©¶å‘ç°ï¼ŒBç»†èƒå¯¹æ‹‰æ²™ç—…æ¯’ç³–è›‹ç™½çš„å…ç–«åŠ›ä¸ç–«è‹—æ¥ç§è¯±å¯¼çš„ç—…æ¯’è½½é‡æ§åˆ¶ç›¸å…³ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311098" target="_blank" rel="noopener noreferrer">GSE311098 CUT&amp;RUN åˆ†æäº†æ¥è‡ªæœªç»æ²»ç–—çš„ä½“å¤– ccRCC å’Œ HGSOC æ‚£è€…æ¥æºçš„å¼‚ç§ç§»æ¤çš„ CD70â» å’Œ CD70âº è‚¿ç˜¤ç»†èƒä¸­ EZH2ã€H3K27me3 å’Œ H3K4me3 çš„å¯Œé›†æƒ…å†µã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297113" target="_blank" rel="noopener noreferrer">GSE297113 çº¿ç²’ä½“ RNA é™è§£åœ¨ AML ä¸­å¢åŠ ï¼Œå¹¶æ§åˆ¶åˆ†åŒ–ã€å¹²ç»†èƒåŠŸèƒ½å’Œå¯¹å…ç–«ä»‹å¯¼æ€ä¼¤çš„æ•æ„Ÿæ€§ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290603" target="_blank" rel="noopener noreferrer">GSE290603 CBFA2T3-GLIS2 é©±åŠ¨çš„å„¿ç«¥æ€¥æ€§å·¨æ ¸ç»†èƒç™½è¡€ç—…ä¸­å¢å¼ºå­ç”²åŸºåŒ–çš„è½¬å½•é‡ç¼–ç¨‹ [DNA ç”²åŸºåŒ–]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289754" target="_blank" rel="noopener noreferrer">GSE289754 è¡¨å¾å°é¼ è‚è„ä¸­ä¸å¹´é¾„ç›¸å…³çš„æŸ“è‰²ä½“å¤–ç¯çŠ¶ DNAï¼šè‚è„è¡°è€çš„æ½œåœ¨ç”Ÿç‰©æ ‡å¿—ç‰© [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314019" target="_blank" rel="noopener noreferrer">GSE314019 ä¹³è…ºç™Œæ­ç¤ºäº† BMPR2 ç›¸å…³çš„æ½œåœ¨è‚ºåŠ¨è„‰é«˜å‹æ˜“æ„Ÿæ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311167" target="_blank" rel="noopener noreferrer">GSE311167 LIPAé¶å‘æ²»ç–—çš„ä¼˜åŒ–ï¼Œä»¥è¯±å¯¼åµå·¢ç™Œå†…è´¨ç½‘åº”æ¿€å’Œç»†èƒæ­»äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309181" target="_blank" rel="noopener noreferrer">GSE309181 è¡€ç®¡åŸºåº•è†œå±‚ç²˜è¿è›‹ç™½è°ƒèŠ‚è„‘å¾®è¡€ç®¡çš„åŠŸèƒ½åˆ†åŒº [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308748" target="_blank" rel="noopener noreferrer">GSE308748 è¡€ç®¡åŸºåº•è†œå±‚ç²˜è¿è›‹ç™½è°ƒèŠ‚è„‘å¾®è¡€ç®¡çš„åŠŸèƒ½åˆ†åŒº [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307794" target="_blank" rel="noopener noreferrer">GSE307794 DhQS æ¿€æ´»å—œçƒ­æ –çƒ­èŒ HB27 ä¸­çš„è½è‰é…¸é€”å¾„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307292" target="_blank" rel="noopener noreferrer">GSE307292 JGOG3025-TR1 åµå·¢é€æ˜ç»†èƒç™Œé˜Ÿåˆ—çš„å¤šç»„å­¦æ•°æ®åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304015" target="_blank" rel="noopener noreferrer">GSE304015 æ³½èŠªæ±¤æŠ‘åˆ¶ä¸­æ€§ç²’ç»†èƒèƒå¤–é™·é˜±å½¢æˆï¼Œä»è€ŒæŠ‘åˆ¶éå°ç»†èƒè‚ºç™Œçš„è¿›å±•å’Œè½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300738" target="_blank" rel="noopener noreferrer">GSE300738 åŸºå› å·¥ç¨‹æ”¹é€ çš„ErbB2è¿‡è¡¨è¾¾å¯å¢å¼ºåŒæºèƒƒç™Œæ¨¡å‹ä¸­ç±»å™¨å®˜æ¥æºè‚¿ç˜¤å¯¹æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚çš„æ•æ„Ÿæ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300509" target="_blank" rel="noopener noreferrer">GSE300509 å¼“å½¢è™«é€Ÿæ®–å­åœ¨ä¸åŒå®¿ä¸»ç»†èƒç³»ä¸Šçš„ä½“å¤–åŸ¹å…»å¯ç­›é€‰å‡ºä¾µè¢­æ•ˆç‡å’Œå¯„ç”Ÿè™«è¡¨é¢æŠ—åŸåŸºå› è¡¨è¾¾çš„å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299569" target="_blank" rel="noopener noreferrer">GSE299569 æ£•æ¦ˆé…¸é€šè¿‡åŒé‡æ£•æ¦ˆé…°åŒ–ä¾èµ–æ€§é€šè·¯æ¿€æ´»c-Mycä¿ƒè¿›ç»“è‚ ç™Œ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294030" target="_blank" rel="noopener noreferrer">GSE294030 IL-36å®¶æ—ç»†èƒå› å­ä»‹å¯¼å¹²ç‡¥ç»¼åˆå¾ä¸­çš„å…ç–«æ¿€æ´»ï¼Œå¹¶å¯èƒ½æˆä¸ºè¯¥ç–¾ç—…çš„æ–°å‹ç”Ÿç‰©æ ‡å¿—ç‰©ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282645" target="_blank" rel="noopener noreferrer">GSE282645è½¬å½•ç»„åŠ¨æ€åˆ†ææ­ç¤ºäº†ç¦½è‡´ç—…æ€§å¤§è‚ æ†èŒæ”»å‡»æœŸé—´è‚è„å’Œè„¾è„çš„æ¢å¤èƒ½åŠ›</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275188" target="_blank" rel="noopener noreferrer">GSE275188 æ·‹å·´å†…çš®ç»†èƒCCL2å¢å¼ºå¿ƒè‚Œæ¢—æ­»åæ·‹å·´ç®¡ç”Ÿæˆå’Œå·¨å™¬ç»†èƒçš„æ·‹å·´æ¸…é™¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE265755" target="_blank" rel="noopener noreferrer">GSE265755 æ¸©åº¦å‡é«˜è¯±å¯¼è£‚æ®–é…µæ¯è½¬å½•æ¿€æ´»åŸºå› ä½“ä¸­ç»„è›‹ç™½çš„Atf1/Pcr1ä¾èµ–æ€§å¿«é€Ÿæ¶ˆè€—</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255302" target="_blank" rel="noopener noreferrer">GSE255302 met1è¡ç”ŸepiRILsçš„åŸºå› ç»„å­¦åˆ†æ[äºšç¡«é…¸æ°¢ç›æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255301" target="_blank" rel="noopener noreferrer">GSE255301 met1è¡ç”ŸepiRILsçš„åŸºå› ç»„å­¦åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244980" target="_blank" rel="noopener noreferrer">GSE244980 ä¿å®ˆçš„è½¬å½•ååº”å¯¹é€†å¢ƒç›¸å…³ç‚ç—‡çš„å“åº”ä¿ƒè¿›æ¢…å°¼åŸƒç—…è¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316714" target="_blank" rel="noopener noreferrer">GSE316714 è¡€ç®¡å¹³æ»‘è‚Œç»†èƒçŠ¶æ€è½¨è¿¹ä»‹å¯¼å† å¿ƒç—…é£é™©çš„åˆ†å­æœºåˆ¶ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316713" target="_blank" rel="noopener noreferrer">GSE316713 è¡€ç®¡å¹³æ»‘è‚Œç»†èƒçŠ¶æ€è½¨è¿¹ä»‹å¯¼å† å¿ƒç—…é£é™©çš„åˆ†å­æœºåˆ¶ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315958" target="_blank" rel="noopener noreferrer">GSE315958 ç™Œç—‡å¯¹äº¤è”æº¶ç˜¤è‚½çš„æ•æ„Ÿæ€§å—è†œèƒ†å›ºé†‡å’Œç‚ç—‡ä¿¡å·ä¼ å¯¼çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309952" target="_blank" rel="noopener noreferrer">GSE309952 IL-7 ç–—æ³•å¯¹æ…¢æ€§ç—…æ¯’æ„ŸæŸ“æœŸé—´ç—…æ¯’ç‰¹å¼‚æ€§ CD8 T ç»†èƒååº”çš„å½±å“ [å¤šç»„å­¦]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309827" target="_blank" rel="noopener noreferrer">GSE309827 CADM1ä½œä¸ºå…ç–«æ²»ç–—é¶ç‚¹çš„é‰´å®šåŠæ–°å‹CADM1é¶å‘æŠ—ä½“è¯ç‰©å¶è”ç‰©åœ¨ä¸´åºŠå‰éª¨è‚‰ç˜¤æ¨¡å‹ä¸­çš„è¯„ä»·</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307106" target="_blank" rel="noopener noreferrer">GSE307106 RNA-seq ç”¨ HDAC æŠ‘åˆ¶å‰‚ panobinostatã€romidepsin å’Œ ricolinostat å¤„ç† OPM2 å¤šå‘æ€§éª¨é«“ç˜¤ç»†èƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302469" target="_blank" rel="noopener noreferrer">GSE302469 ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶æŠ‘åˆ¶å‰‚ SAHA å¯¹è‚ºè…ºç™Œå’Œè‚ºé³ç™Œè½¬å½•ç»„çš„å·®å¼‚æ€§è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291425" target="_blank" rel="noopener noreferrer">GSE291425 äººç±»å¿ƒè„æˆçº¤ç»´ç»†èƒ (HCF) ä¸­ NAV3 æ•²ä½çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279687" target="_blank" rel="noopener noreferrer">GSE279687 HIV-1 åˆ©ç”¨ LEDGF åœ¨è½¬å½•ä¸­çš„ä½œç”¨æ¥å®šä½æ•´åˆ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278223" target="_blank" rel="noopener noreferrer">GSE278223 IL-7ç–—æ³•å¯¹æ…¢æ€§ç—…æ¯’æ„ŸæŸ“æœŸé—´ç—…æ¯’ç‰¹å¼‚æ€§CD8 Tç»†èƒååº”çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320402" target="_blank" rel="noopener noreferrer">GSE320402 å°é¼ å¬ç¥ç»è¡°è€ç›¸å…³åˆ†å­å˜åŒ–çš„ç‰¹å¾åˆ†æ[é‡æ–°åˆ†æ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314474" target="_blank" rel="noopener noreferrer">GSE314474 æµ·ä¸ƒé³ƒé³—èƒšèƒç¨‹åºæ€§DNAæ¶ˆé™¤è¿‡ç¨‹ä¸­ç»„è›‹ç™½ç”²åŸºè½¬ç§»é…¶çš„åŠŸèƒ½åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303852" target="_blank" rel="noopener noreferrer">GSE303852 è‚¥èƒ–å°é¼ æ¥å— Roux-en-Y èƒƒæ—è·¯æ‰‹æœ¯æˆ–å‡æ‰‹æœ¯åï¼Œåˆ†åˆ«åœ¨æ™®é€šé¥²æ–™æˆ–é«˜è„‚é¥²æ–™æ¡ä»¶ä¸‹è¿›è¡Œè‚è„ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300278" target="_blank" rel="noopener noreferrer">GSE300278 äººç±»ç—£åŠå…¶é‚»è¿‘æ­£å¸¸çš®è‚¤æ€»RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291177" target="_blank" rel="noopener noreferrer">GSE291177 RNAæµ‹åºç ”ç©¶UVBè¯±å¯¼çš„å¤§é¼ çœ¼éƒ¨ç«ç‘°ç—¤ç–®æ¨¡å‹ä¸­ç›çš®è´¨æ¿€ç´ å—ä½“ï¼ˆMRï¼‰è¿‡è¡¨è¾¾æƒ…å†µ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320165" target="_blank" rel="noopener noreferrer">GSE320165 åŸºå› ç»„ç¼–è¾‘ä¸­æœ€å¤§é™åº¦å‡å°‘å¤§èŒƒå›´æŸ“è‰²è´¨æ‰°åŠ¨å¯ä¿æŒå¹²ç»†èƒç‰¹æ€§ [Cut&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320164" target="_blank" rel="noopener noreferrer">GSE320164 åŸºå› ç»„ç¼–è¾‘ä¸­æœ€å¤§é™åº¦å‡å°‘å¤§èŒƒå›´æŸ“è‰²è´¨æ‰°åŠ¨å¯ä¿æŒå¹²ç»†èƒç‰¹æ€§ [PEM-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320037" target="_blank" rel="noopener noreferrer">GSE320037 H3K79me2 åˆ†ææ­ç¤º MLL é‡æ’ AML ä¸­ DOT1L è°ƒæ§çš„å‰ªæ¥ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320036" target="_blank" rel="noopener noreferrer">GSE320036 H3K79me2 åˆ†ææ­ç¤º MLL é‡æ’ AML ä¸­ DOT1L è°ƒæ§çš„å‰ªæ¥ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320001" target="_blank" rel="noopener noreferrer">GSE320001 Parp7-/-è‚ºçš„å•æ ¸è½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311802" target="_blank" rel="noopener noreferrer">GSE311802ï¼šKDM5Bç»„è›‹ç™½èµ–æ°¨é…¸å»ç”²åŸºåŒ–é…¶ç¼ºé™·å°é¼ å‡ºç°è‡ªé—­ç—‡æ ·è¡¨å‹å’ŒNMDAR2Dè¡¨è¾¾å¢åŠ </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311096" target="_blank" rel="noopener noreferrer">GSE311096 æ•æ„Ÿ CAR T ç»†èƒé‡æ–°å®šä¹‰äº†å®ä½“ç˜¤ä¸­å¯é¶å‘çš„ CD70 è¡¨è¾¾ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308040" target="_blank" rel="noopener noreferrer">GSE308040 AID åœ¨å¼¥æ¼«æ€§å¤§Bç»†èƒæ·‹å·´ç˜¤ä¸­è°ƒæ§MYC/E2Fé¶åŸºå› æ¿€æ´»å’Œç»†èƒèµ·æºè½¬å½•ç¨‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306609" target="_blank" rel="noopener noreferrer">GSE306609 æ•æ„Ÿ CAR T ç»†èƒé‡æ–°å®šä¹‰äº†å®ä½“ç˜¤ä¸­å¯é¶å‘çš„ CD70 è¡¨è¾¾ [RNA-seq RCC]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306267" target="_blank" rel="noopener noreferrer">GSE306267 æ•æ„Ÿ CAR T ç»†èƒé‡æ–°å®šä¹‰äº†å®ä½“ç˜¤ä¸­å¯é¶å‘çš„ CD70 è¡¨è¾¾ [RNA-seq OV]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300836" target="_blank" rel="noopener noreferrer">GSE300836 TopBP1 é€šè¿‡ PU.1 å’Œ IRF8 æ§åˆ¶å¸¸è§„æ ‘çªçŠ¶ç»†èƒå‘è‚²å’Œ Flt3L é©±åŠ¨çš„ cDC1 åˆ†åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297114" target="_blank" rel="noopener noreferrer">GSE297114 çº¿ç²’ä½“RNAé™è§£åœ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ï¼ˆAMLï¼‰ä¸­å¢åŠ ï¼Œå¹¶æ§åˆ¶åˆ†åŒ–ã€å¹²ç»†èƒåŠŸèƒ½å’Œå¯¹å…ç–«ä»‹å¯¼æ€ä¼¤çš„æ•æ„Ÿæ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297053" target="_blank" rel="noopener noreferrer">GSE297053 çº¿ç²’ä½“ RNA é™è§£åœ¨ AML ä¸­å¢åŠ ï¼Œå¹¶æ§åˆ¶åˆ†åŒ–ã€å¹²ç»†èƒåŠŸèƒ½å’Œå¯¹å…ç–«ä»‹å¯¼æ€ä¼¤çš„æ•æ„Ÿæ€§ [NS_Immunology_v2_C2328]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290689" target="_blank" rel="noopener noreferrer">GSE290689 åˆ©ç”¨æ ¸ç³–ä½“æ ‡è®°å¢å¼ºå‹RNAæµ‹åºè¡¨å¾çƒå­¢å­èŒå½¢æ€çš„è½¬å½•ç»„å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290584" target="_blank" rel="noopener noreferrer">GSE290584 æ ¸ç³–ä½“ç”Ÿç‰©åˆæˆåŠå…¶ç”±è¾“å‡ºè›‹ç™½ CSE1L è°ƒæ§ï¼Œæ˜¯å„¿ç«¥å’Œé’å¹´æ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­çš„é€‰æ‹©æ€§ä¾èµ–æ€§ 4</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275358" target="_blank" rel="noopener noreferrer">GSE275358 ç»†èƒå­˜æ´»åå€šä½œä¸ºè‚Œè‚‰å¹²ç»†èƒè¡°è€çš„æœºåˆ¶é©±åŠ¨å› ç´ </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270932" target="_blank" rel="noopener noreferrer">GSE270932 é¼»è…” CD4âº ç»„ç»‡é©»ç•™è®°å¿† T ç»†èƒæä¾›å¯¹æµæ„Ÿçš„äº¤å‰ä¿æŠ¤æ€§å…ç–«</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268013" target="_blank" rel="noopener noreferrer">GSE268013 è¯±å¯¼å¹²ç»†èƒè¡ç”Ÿèƒ°å²›çš„å•ç»†èƒRNAæµ‹åºåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221578" target="_blank" rel="noopener noreferrer">GSE221578 åŸºäº CRISPR çš„åŸºå› ç­›é€‰ï¼Œç”¨äºç ”ç©¶ AML æ‚£è€…ç»†èƒä¸­è‚¿ç˜¤ç»´æŒå’Œå¼‚è´¨æ€§çš„æ²»ç–—é¶ç‚¹</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-26 21:50</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>